Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1450 |
|---|---|
| Identifier | NCT03196427 |
| Trial Title | Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease |
| Interventions | DRUG: Vedolizumab |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-07-30 |
|---|---|
| Primary Completion Date | 2025-05-26 |
| Completion Date | 2025-11-24 |